Table 2.
2017 | Total | Monotherapy | Dual Therapy | Three or More Classes Therapy | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | (%) | Days of Prescription | n | (%) | Days of Prescription | n | (%) | Days of Prescription | n | (%) | Days of Prescription | |
Overall | 9,357,751 | 100.0 | 283.5 | 4,120,642 | 44.0 | 268.8 | 3,812,327 | 40.7 | 294.1 | 1,424,782 | 15.2 | 297.6 |
≤29 | 132,678 | 100.0 | 180.5 | 106,313 | 80.1 | 170.5 | 19,063 | 14.4 | 215.1 | 7,302 | 5.5 | 235.6 |
30–49 | 1,565,263 | 100.0 | 255.0 | 696,900 | 44.5 | 230.5 | 657,579 | 42.0 | 272.8 | 210,784 | 13.5 | 280.2 |
50–69 | 4,975,873 | 100.0 | 291.3 | 2,194,413 | 44.1 | 279.3 | 2,070,238 | 41.6 | 299.9 | 711,222 | 14.3 | 303.4 |
≥70 | 2,683,937 | 100.0 | 290.6 | 1,123,016 | 41.8 | 281.2 | 1,065,447 | 39.7 | 297.1 | 495,474 | 18.5 | 297.7 |
Male | 4,701,919 | 100.0 | 280.6 | 1,924,683 | 40.9 | 264.8 | 1,998,657 | 42.5 | 290.2 | 778,579 | 16.6 | 294.9 |
≤29 | 75,594 | 100.0 | 193.9 | 54,519 | 72.1 | 183.9 | 15,038 | 19.9 | 213.4 | 6,037 | 8.0 | 236.0 |
30–49 | 1,003,780 | 100.0 | 259.5 | 388,647 | 38.7 | 236.5 | 457,014 | 45.5 | 271.8 | 158,119 | 15.8 | 280.5 |
50–69 | 2,629,904 | 100.0 | 289.1 | 1,058,392 | 40.2 | 275.7 | 1,144,637 | 43.5 | 297.0 | 426,875 | 16.2 | 301.2 |
≥70 | 992,641 | 100.0 | 285.9 | 423,125 | 42.6 | 274.1 | 381,968 | 38.5 | 294.6 | 187,548 | 18.9 | 294.7 |
Female | 4,655,832 | 100.0 | 286.4 | 2,195,959 | 47.2 | 272.3 | 1,813,670 | 39.0 | 298.3 | 646,203 | 13.9 | 300.8 |
≤29 | 57,084 | 100.0 | 162.8 | 51,794 | 90.7 | 156.5 | 4,025 | 7.1 | 221.6 | 1,265 | 2.2 | 233.6 |
30–49 | 561,483 | 100.0 | 246.9 | 308,253 | 54.9 | 223.0 | 200,565 | 35.7 | 275.3 | 52,665 | 9.4 | 279.1 |
50–69 | 2,345,969 | 100.0 | 293.8 | 1,136,021 | 48.4 | 282.7 | 925,601 | 39.5 | 303.5 | 284,347 | 12.1 | 306.6 |
≥70 | 1,691,296 | 100.0 | 293.3 | 699,891 | 41.4 | 285.5 | 683,479 | 40.4 | 298.5 | 307,926 | 18.2 | 299.5 |